67 Researchers at the Indian Institute of Technology (IIT) in Madras, Tel Aviv University, and Columbia University are working to develop a treatment for a rare genetic brain disease called GNB1 Encephalopathy. This neurological disorder affects fetuses and has fewer than 100 documented cases worldwide. Symptoms of GNB1 Encephalopathy include delayed physical and mental development, intellectual disabilities, and frequent epileptic seizures. Due to the high cost of genome sequencing, not many parents opt for it early on, making it difficult to diagnose and treat the disease in its early stages. You Might Be Interested In Unlocking India’s High-Growth Demographic Dividend Requires Investment in Human Capital Tok Mat refutes Annuar Musa's claims two million Umno members had quit party Afghanistan sees suspension of Foreign Aid operations as Taliban bans women working in NGOs PM’s secy reviews G20 outcome follow-up, asks to prepare for virtual summit A rotting warship becomes a flashpoint for Sino-American rivalry WHO chief pushes China for ‘full access’ to solve Covid’s origins
